- Business
- XRF Scientific Limited manufactures and markets equipment, chemicals and precious metal products for sample preparation and analysis in the scientific, analytical and mining industries; its core offerings include X-ray fluorescence (XRF) fusion equipment such as xrFuse machines, pulverising mills, high-purity flux chemicals including lithium borates, platinum labware for high-temperature processes, carbon sulphur analysers, pH analysers, laboratory weighing systems and Orbis Mining jaw crushers; the company operates three main divisions encompassing consumables, precious metals and capital equipment, serving production mines, construction material companies, commercial analytical laboratories and sectors such as metals, mining, chemicals and petrochemicals; XRF maintains manufacturing, sales and support facilities in Perth and Melbourne Australia, Europe and Canada, with a global distribution network covering the United States, South America, Africa, the Middle East and Asia. Founded in 1972 and headquartered at 86 Guthrie Street, Osborne Park, Perth, Western Australia, the Australian-listed company (ASX: XRF) reported record fiscal 2025 results with revenue of $59.5 million and net profit after tax attributable to members of $10.4 million, up 17% from the prior year, driven by strong consumables performance, Orbis Mining contributions and improved European operations. In recent strategic developments, XRF completed the acquisition of the remaining 50% of Orbis Mining in July 2024 for $3.9 million to gain full control of its jaw crusher business, which saw profit before tax rise 39% to $2.4 million amid market share gains and a new Americas distributor appointment with STG Mining Supplies; the company also acquired Labfit Pty Ltd in December 2024 for $1.2 million, integrating its carbon sulphur analysers, pH analysers and weighing systems into the Perth capital equipment factory to diversify into water, beverage, environmental and agriculture sectors; ongoing initiatives include xrTGA instrument market acceptance, new complementary Orbis products for fiscal 2025 launch, enhanced Melbourne platinum production technology and international sales growth in Asia, Americas and Europe, alongside a 15% increase in the final fully franked dividend to 4.5 cents per share.